ADH5 and liver disorder: Cox et al. [21] reported that GSNOR exacerbated acetaminophen-induced liver disease by activating Keap 1 via denitrosylation and inhibiting the cytoprotective nuclear erythroid 2-related factor 2 (Nrf 2) pathways.